Total Utang marang Modal InfuSystem Inc (INFU)

InfuSystem (INFU) - logo korporat

This chart illustrates that the market valuation of the total debt-to-equity ratio for InfuSystem Holdings (INFU) stands at 0.36. InfuSystem Holdings (INFU) minimizes risks by providing ancillary services and pump rentals for surgical and oncology centers. Business efficiency is based on a network of regional hubs that accelerate deliveries to hospitals. System stability is maintained through the retention of skilled technicians and the strategic hiring of sales representatives.

INFU: Rasio Utang marang Ekuitas InfuSystem 04.07.2022 - 29.10.2026

Rincian analitis perusahaan InfuSystem Holdings

- rega lan prakiraan konsensus rega:
Bagan rega InfuSystem|INFU - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar InfuSystem Holdings|INFU - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham InfuSystem Holdings|INFU - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku infusystem.com|INFU - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal InfuSystem Holdings|INFU - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal InfuSystem|INFU - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku InfuSystem Holdings|INFU - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan InfuSystem Holdings
Analisis dhasar perusahaan:INFU, InfuSystem Holdings
Produk dadi InfuSystem Holdings, Inc.

InfuSystem Holdings (INFU) is actively investing in robotics and telemetry to automate the maintenance of medical equipment. This metric measures the proportion of debt relative to equity, determining the company's degree of financial leverage. It is critical for investors to find a balance between aggressive growth and the risk of insolvency. Excessively low values may indicate business stagnation. The trend in the debt-to-equity ratio clearly demonstrates the model's resilience to external shocks.

Pesaing wigati

Utang marang Ekuitas Intuitive|Rasio Total Utang marang Ekuitas Danaher Corporation (DHR)|Total Utang marang Modal BDX|STE - Utang marang Modal|Total Utang marang Modal WST (West Pharmaceutical Services)|BAX: Rasio Utang marang Ekuitas|Masimo - Total Utang marang Modal|Koefisien Total Utang marang Modal Stevanato Group SpA STVN|TFX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Merit Medical Corp|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal icumed.com|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STAA|ChromaDex Corp. - Total Utang marang Modal|Koefisien Total Utang marang Modal zimvie.com ZIMV|AngioDynamics (ANGO) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CERS|Utang marang Ekuitas Alpha Teknova Inc|Monogram Orthopedics Inc. (MGRM) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas STSS (Sharps Technology, Inc.)|Utang Agregat marang Modal UTMD|Utang marang Ekuitas KORU Medical KRMD|Rasio Kabeh Utang marang Dana Pribadi NYXH|MBOT: Rasio Total Utang marang Ekuitas|PDEX - Total Utang marang Modal|Zentek Ltd. (ZTEK) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas elutia.com|MLSS (Milestone Scientific Inc.) - Total Utang marang Modal|Utang marang Modal NEXGEL Inc. NXGL|Utang marang Ekuitas Retractable Technologies (RVP)|harvardbioscience.com - Rasio Utang marang Ekuitas|Femasys Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal MHUA (Meihua Medical Technologies)|POAI - Utang marang Ekuitas|Koefisien Total Utang marang Modal Callan JMB Inc CJMB|ATRI: Total Utang marang Modal|NURO - Koefisien Total Utang marang Modal